Clinical Trial Update: Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of combining low-dose cytarabine with thalidomide in adults with untreated Langerhans cell histio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• Cytarabine (Low-Dose) (cytarabine)
• Thalidomide (thalidomide)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Langerhans Cell Histiocytosis | Phase 2 | Status: RECRUITING